Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06675240 · ClinicalTrials.gov registry record · NA

Meditative Neurofeedback for Depression

A NA study of Depression - Major Depressive Disorder and Depression Disorders, sponsored by University of California, San Diego.

Recruiting
Registry status
NA
Development phase
27
Enrollment target
1
Study location

NCT06675240 is a NA study of Depression - Major Depressive Disorder and Depression Disorders that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 27 participants, below the 101-participant average among 19 other Depression - Major Depressive Disorder trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06675240, a NA study of Depression - Major Depressive Disorder and Depression Disorders, is actively recruiting participants, sponsored by University of California, San Diego.

RECRUITING
Registry status
NA
Development phase
27 participants
Enrollment target
1
Study location

Study Summary

The goal of this open-label single-arm study is to test a meditative neurofeedback intervention for depressed mood.

Interventions

  • BEHAVIORAL MediNF

Study Locations (1)

California

  • University of California San Diego - La Jolla

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2024-11-15
Est. Completion 2027-06-15
Phase NA

Sponsor

University of California, San Diego

775 total trials

What the Registry Record Tells You About NCT06675240

The ClinicalTrials.gov registry entry for NCT06675240 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 101-participant average among 19 other Depression - Major Depressive Disorder trials with a reported enrollment target (73% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Depression - Major Depressive Disorder appearing as the primary indexed condition, and to 1 intervention - of which MediNF is the first listed.

NCT06675240 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06675240 about?

NCT06675240 is a clinical study titled "Meditative Neurofeedback for Depression". The goal of this open-label single-arm study is to test a meditative neurofeedback intervention for depressed mood.

What is the current status of trial NCT06675240?

This trial is currently recruiting. It is a NA study. The enrollment target is 27 participants. The study started on 2024-11-15. Estimated completion is 2027-06-15.

What conditions does trial NCT06675240 study?

This clinical trial studies the following conditions: Depression - Major Depressive Disorder, Depression Disorders.

What interventions are being tested in trial NCT06675240?

The interventions under investigation include: MediNF (BEHAVIORAL).

Who is sponsoring clinical trial NCT06675240?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06675240 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression - Major Depressive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.